• Latest Posts

Replay Bio launches HSV gene therapy company to target retinal eye disease

New Replay HSV gene therapy company Telaria to focus on skin diseases

Replay targets genetic brain disorders with new gene therapy company, Kaleibe


MedinCell’s partner AIC registers trial for drug for total knee replacement pain

Incyte to acquire Medicxi-backed Villaris Therapeutics to tackle vitiligo

Arcutis Biotherapeutics acquires Ducentis BioTherapeutics in deal worth up to $400M

Are these 10 biotech recruiters on your radar this year?

The five hottest private biotech companies in San Diego